📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The discovery of new and more potent chloropyramine (C4) analogues for the potential treatment of invasive breast cancer. (2018)

First Author: Kandil S

Attributed to: Accelerating translational research through Cardiff University’s Clinical Innovation pipeline funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/cbdd.13083

PubMed Identifier: 28816016

Publication URI: http://europepmc.org/abstract/MED/28816016

Type: Journal Article/Review

Volume: 91

Parent Publication: Chemical biology & drug design

Issue: 1

ISSN: 1747-0277